BioLineRx BLRX
NASDAQ BLRX
$2.34 +0.02 (+0.86%)
As of: Oct 1, 2026 · 2:58 PM EDT

BioLineRx (BLRX) Accumulated Expenses (2016 - 2020)

Updated

BioLineRx (BLRX) posted Accumulated Expenses of $884,000 for the quarter ended Dec 31, 2020, up 21.6% from $727,000 a year earlier.

Analysis

BioLineRx (BLRX) Accumulated Expenses (2016 - 2020) Analysis & Trends

Since the quarter ended Dec 31, 2016, BioLineRx has reported Accumulated Expenses for 5 quarters.

  • Annual Accumulated Expenses shows a four-year compound annual growth rate of 12.1% (years ended Dec 2016 to Dec 2020).
  • In prior years, BioLineRx's Accumulated Expenses was $727,000 in the year ended Dec 31, 2019 (-8.2%), $792,000 in the year ended Dec 31, 2018 (+27.7%), $620,000 in the year ended Dec 31, 2017 (+10.7%) and $560,000 in the year ended Dec 31, 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 BioLineRx 6.14 Bn 6.14 Bn 235,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 884,000.00
Dec 31, 2019 727,000.00
Dec 31, 2018 792,000.00
Dec 31, 2017 620,000.00
Dec 31, 2016 560,000.00
API Access

BioLineRx Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BLRX&period=max&api_key=YOUR_API_KEY